相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Promoter Polymorphisms in ACE (Angiotensin I-Converting Enzyme) Associated With Clinical Outcomes in Hypertension
A. D. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Carryover effects after cessation of drug treatment: Trophies or dreams?
Thomas Lumley et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism:: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) trial
Lisa Kurland et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
beta 1- and beta 2-adrenergic receptor gene beta-blocker use and risk of myocardial infarction and stroke
Rozenn N. Lemaitre et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Biostatistical aspects of genome-wide association studies
Andreas Ziegler et al.
BIOMETRICAL JOURNAL (2008)
Thiazide-type diuretics and β-adrenergic blockers as first-line drug treatments for hypertension
Jeffrey A. Cutler et al.
CIRCULATION (2008)
Risk/benefit assessment of β-blockers and diuretics precludes their use for first-line therapy in hypertension
Franz H. Messerli et al.
CIRCULATION (2008)
Heart disease and stroke statistics - 2008 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Wayne Rosamond et al.
CIRCULATION (2008)
β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in Hypertension
M. A. Pacanowski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic
Stephen T. Turner et al.
HYPERTENSION (2008)
Physiological interaction between α-adducin and WNK1-NEDD4L pathways on sodium-related blood pressure regulation
Paolo Manunta et al.
HYPERTENSION (2008)
Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension
Amy I. Lynch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with β-blockade
A. Kelley-Hedgepeth et al.
JOURNAL OF HUMAN HYPERTENSION (2008)
The pressure of finding human hypertension genes: new tools, old dilemmas
F. J. Charchar et al.
JOURNAL OF HUMAN HYPERTENSION (2008)
Clinical variables, not RAAS polymorphisms, predict blood pressure response to ACE inhibitors in Sardinians
Fabiana Filigheddu et al.
PHARMACOGENOMICS (2008)
Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke
H. Schelleman et al.
PHARMACOGENOMICS JOURNAL (2008)
Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome
Haralampos J. Milionis et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2007)
Meta-analysis of 94,492 patients with hypertension treated with beta Blockers to determine the risk of new-onset diabetes Mellitus
Sripal Bangalore et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
KCNMB1 genotype influences response to verapamil SIR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST)
Amber L. Beitelshees et al.
PHARMACOGENETICS AND GENOMICS (2007)
Pharmacogenetics of β-blockers
Jaekyu Shin et al.
PHARMACOTHERAPY (2007)
Enzymes and pharmacogenetics of cardiovascular drugs
Gerard Siest et al.
CLINICA CHIMICA ACTA (2007)
Variability in response to antihypertensive drugs
Barry J. Materson
AMERICAN JOURNAL OF MEDICINE (2007)
Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or β-blockers
Hedi Schelleman et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2007)
Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamil
T. Y. Langaee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Pharmacogenetics of the human beta-adrenergic receptors
M. R. G. Taylor
PHARMACOGENOMICS JOURNAL (2007)
Exploring design-related bias in clinical studies on receptor genetic polymorphism of hypertension
Pendar Farahani et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
β1-adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension
Jie Liu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Are all the hypertensives made equal?
Arnljot Flaa et al.
HERZ (2006)
Feasibility of treating prehypertension with an angiotensin-receptor blocker
S Julius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pharmacogenomics and pharmacogenetics of hypertension: Update and perspectives - The adducin paradigm
Paolo Manunta et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension
T Bremer et al.
PHARMACOGENOMICS (2006)
Pharmacogenetics of antihypertensive treatment
DK Arnett et al.
VASCULAR PHARMACOLOGY (2006)
β2-Adrenergic receptor genotype and survival among patients receiving β-blocker therapy after an acute coronary syndrome
DE Lanfear et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Ser49Gly of β1-adrenergic receptor is associated with effective β-blocker dose in dilated cardiomyopathy
Y Magnusson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Pharmacogenomics of blood pressure response to anti hypertensive treatment
PB Mellen et al.
JOURNAL OF HYPERTENSION (2005)
Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment - The genetics of hypertension-associated treatment (GenHAT) study
DK Arnett et al.
CIRCULATION (2005)
Interarm differences in seated systolic and diastolic blood pressure: the Hypertension Genetic Epidemiology Network study
DK Arnett et al.
JOURNAL OF HYPERTENSION (2005)
A multilocus approach to the anti hypertensive pharmacogenetics of hydrochlorothiazide
AH Maitland-Van Der Zee et al.
PHARMACOGENETICS AND GENOMICS (2005)
ß2-Adrenergic receptor polymorphisms and determinants of cardiovascular risk:: The Cardiovascular Health Study
LA Hindorff et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
A transcriptional profile of aging in the human kidney
GEJ Rodwell et al.
PLOS BIOLOGY (2004)
Beta1-adrenergic receptor gene polymorphisms and response to betal1-adrenergic receptor blockade in patients with essential hypertension
J Karlsson et al.
CLINICAL CARDIOLOGY (2004)
Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade
F Filigheddu et al.
PHARMACOGENOMICS JOURNAL (2004)
Multilocus effects of the renin-angiotensin-aldosterone system genes on blood pressure response to a thiazide diuretic
L Frazier et al.
PHARMACOGENOMICS JOURNAL (2004)
Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients
JC Bis et al.
AMERICAN JOURNAL OF HYPERTENSION (2003)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
Effects of endothelial nitric oxide synthase, α-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide
ST Turner et al.
AMERICAN JOURNAL OF HYPERTENSION (2003)
Gly389Arg polymorphism of β1-adenergic receptor is associated with the cardiovascular response to metoprolol
J Liu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
β-Adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure
DM Kaye et al.
PHARMACOGENETICS (2003)
β1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol
JA Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
A common β1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to β-blockade
GG Sofowora et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
ACE and α-adducin polymorphism as markers of individual response to diuretic therapy
MT Sciarrone et al.
HYPERTENSION (2003)
Reproducibility of home, ambulatory, and clinic blood pressure: Implications for the design of trials for the assessment of antihypertensive drug efficacy
GS Stergiou et al.
AMERICAN JOURNAL OF HYPERTENSION (2002)
The effect of common polymorphisms of the β2-adrenergic receptor on agonist-mediated vascular desensitization
V Dishy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
C825T polymorphism of the G protein β3-subunit and antihypertensive response to a thiazide diuretic
ST Turner et al.
HYPERTENSION (2001)
Predicting response to chronic antihypertensive treatment with fosinopril: The role of angiotensin-converting enzyme gene polymorphism
GA Stavroulakis et al.
CARDIOVASCULAR DRUGS AND THERAPY (2000)
分享论文
